Nova Pneuma
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.novapneuma.comRevenue
$5.4 MillionIndustry
ZI Rank: 1
About Nova Pneuma
Nova Pneuma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nova Pneuma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Nova Pneuma launches new products
Nova Pneuma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Nova Pneuma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Nova Pneuma
Funding: Get notified immidiatlly once Nova Pneuma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Nova Pneuma has recently received funding, and reach out quickly before it becomes old news!
Check out if Nova Pneuma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Nova Pneuma had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Nova Pneuma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nova Pneuma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nova Pneuma.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nova Pneuma
Nova Pneuma is a clinical-stage biotechnology company focused on developing rapid-onset therapies for acute medical conditions where immediate treatment is critical. A wholly owned subsidiary of Lees Pharmaceutical Holdings, the company utilizes its proprietary Staccato® One Breath Technology® platform to deliver inhaled therapies with fast, IV-lik... Read More
